DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
复制标题
DOI:
10.1158/1940-6207.capr-09-0229
复制
发表时间:
2010-02
期刊:
影响因子:
--
通讯作者:
Tlsty T
中科院分区:
文献类型:
--
作者:
Fordyce C;Fessenden T;Pickering C;Jung J;Singla V;Berman H;Tlsty T
COX-2 catalyzes the rate-limiting step in the synthesis of prostaglandins. Its overexpression induces numerous tumor-promoting phenotypes and is associated with cancer metastasis and poor clinical outcome. Although COX-2 inhibitors are promising chemotherapeutic and chemopreventative agents for cancer, the risk of significant cardiovascular and gastrointestinal complications currently outweighs their potential benefits. Systemic complications of COX-2 inhibition could be avoided by specifically decreasing COX-2 expression in epithelial cells. To that end, we have investigated the signal transduction pathway regulating COX-2 expression in response to DNA damage in breast epithelial cells. In variant human mammary epithelial cells that have silenced p16 (vHMEC), double strand DNA damage or telomere malfunction results in a p53-and activin A-dependent induction of COX-2 and continued proliferation. In contrast, telomere malfunction in HMEC with an intact p16/Rb pathway induces cell cycle arrest. Importantly, in ductal carcinoma in situ (DCIS) lesions, high COX-2 expression is associated with high γH2AX, TRF2, activin A and telomere malfunction. These data demonstrate that DNA damage and telomere malfunction can have both cell autonomous and cell non-autonomous consequences and provides a novel mechanism for the propagation of tumorigenesis.